Absci Corporation (ABSI) vs Celldex Therapeutics, Inc. (CLDX)
A side-by-side comparison of Absci Corporation and Celldex Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABSI
Absci Corporation
$10.93HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
CLDX
Celldex Therapeutics, Inc.
$31.70HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Total return — ABSI vs CLDX
growth of $100 · dividends reinvested · last 5yABSI -46.6% (-11.8%/yr)CLDX -26.9% (-6.1%/yr)CLDX compounded faster over this window
ABSI CLDX
ABSI vs CLDX: by the numbers
- •CLDX is the larger company ($2.11B vs $1.85B market cap).
- •Both run net losses; ABSI's is the smaller (-7756.37% vs -268385.71% net margin).
- •Both shrank revenue over the past five years; ABSI's decline was smaller (-22.08% vs -58.05% CAGR).
Metrics side by side
Valuation
| Metric | ABSI | CLDX |
|---|---|---|
| P/S ratio | 1186.13 | 18834.48 |
| P/B ratio | 7.52 | 2.95 |
Profitability
| Metric | ABSI | CLDX |
|---|---|---|
| Gross margin | -319.36% | 100.00% |
| Operating margin | -4454.21% | -19160.00% |
| Net margin | -7756.37% | -268385.71% |
| ROE | -49.19% | -42.07% |
| ROIC | -52.66% | -45.19% |
Growth (annualized)
| Metric | ABSI | CLDX |
|---|---|---|
| Revenue CAGR (5Y) | -22.08% | -58.05% |
| Total return CAGR (5Y) | 0.89% | -10.28% |
Frequently asked
- Which has grown faster, ABSI or CLDX?
- Neither grew: over the past five years both shrank revenue, with ABSI's decline the smaller — ABSI at a -22.08% CAGR versus CLDX at -58.05%.
- How have ABSI and CLDX total returns compared?
- Over the past 5 years, ABSI delivered 0.89% and CLDX delivered -10.28% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.